Reata Pharmaceuticals Inc
RETADelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001358762
Reata Pharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Reata Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Reata Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| CPMG Inc | Director, 10% Owner | 0Indirect | Sep 28, 2023 | 0 |
| Desai Antal Rohit | Director, 10% Owner | 0Indirect | Sep 28, 2023 | 0 |
| Wortley Michael D | Chief Legal Officer | 0 | Sep 26, 2023 | 0 |
| Rose William | Director | 0Indirect | Sep 26, 2023 | 0 |
| McGaughy R Kent Jr | Director, 10% Owner | 0Indirect | Sep 26, 2023 | 0 |
| Soni Manmeet Singh | COO, CFO and President | 0 | Sep 26, 2023 | 0 |
| Loewen Andrea | SVP, Global Regulatory Affairs | 0 | Sep 26, 2023 | 0 |
| Patni Rajiv | EVP, Chief R&D Officer | 0 | Sep 26, 2023 | 0 |
| Edwards Martin | Director | 0 | Sep 26, 2023 | 0 |
| Meyer Colin John | Chief Innovation Officer | 0 | Sep 26, 2023 | 0 |
| Huff James Warren | Chief Executive Officer | 0Indirect | Sep 26, 2023 | 0 |
| Ruff Shamim | Director | 0 | Sep 26, 2023 | 0 |
| Bir Dawn Carter | Chief Commercial Officer | 0 | Sep 26, 2023 | 0 |
| McClellan William D. Jr. | Director | 0 | Sep 26, 2023 | 0 |
| Oliger Christy J. | Director | 0 | Sep 26, 2023 | 0 |
| Ryder Steven | Director | 0 | Sep 26, 2023 | 0 |
| Anand Bhaskar | SVP, Chief Accounting Officer | 0 | Sep 26, 2023 | 0 |
| Khan Samina | SVP, Chief Medical Officer | 39,491 | May 17, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 (view filing) | Sep 14 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −3.17K | $172.03 | −$546.2K | −10.1%28.4K after | |
| Sep 7, 2023 (view filing) | Sep 5 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −406 | $169.20 | −$68.7K | −1.7%24.1K after | |
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Wortley Michael DChief Legal Officer | SSaleClass A common stock | −1.21K | $168.95 | −$203.6K | −2.4%49.7K after | 2 lots |
| Aug 17, 2023 (view filing) | Aug 16 | 1 day | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −1.75K | $168.41 | −$295.6K | −2.7%62.6K after | |
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Meyer Colin JohnChief Innovation Officer | SSaleClass A common stock | −2.74K | $169.00 | −$463.1K | −3.2%81.6K after | 2 lots |
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −1.21K | $168.81 | −$203.4K | −3.4%33.8K after | 2 lots |
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −403 | $168.73 | −$68.0K | −1.6%24.5K after | 2 lots |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −75.0K | $164.62 | −$12.3M | −53.8%64.4K after | 10b5-1 |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Ruff ShamimDirector | SSaleClass A common stock | −8.23K | $164.53 | −$1.35M | −52.8%7.36K after | 10b5-1 |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | McClellan William D. Jr.Director | SSaleClass A common stock | −5.00K | $164.49 | −$822.5K | −45.4%6.02K after | 10b5-1 |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −40.0K | $164.54 | −$6.58M | −53.3%35.0K after | 10b5-1 |
| Jun 16, 2023 (view filing) | Jun 14 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −2.34K | $102.11 | −$239.2K | −8.6%24.9K after | |
| Jun 14, 2023 (view filing) | Jun 12-13 | 2 days | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −82.8K | $102.71 | −$8.50M | −58.6%58.4K after | 8 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Wortley Michael DChief Legal Officer | SSaleClass A common stock | −1.31K | $83.59 | −$109.6K | −2.7%46.8K after | 2 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −22.1K | $84.45 | −$1.87M | −16.0%116.2K after | 4 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Meyer Colin JohnChief Innovation Officer | SSaleClass A common stock | −6.23K | $84.56 | −$527.1K | −7.4%78.4K after | 3 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −640 | $83.15 | −$53.2K | −1.6%39.5K after | 2 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −1.09K | $85.37 | −$92.7K | −4.1%25.7K after | 2 lots |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −1.31K | $83.78 | −$109.8K | −4.1%30.9K after | 2 lots |
| May 16, 2023 (view filing) | May 12-16 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −7.17K | $86.01 | −$616.3K | −18.5%31.6K after | 3 lots |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −9.32K | $86.77 | −$808.4K | −22.4%32.2K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Ruff ShamimDirector | SSaleClass A common stock | −5.74K | $83.73 | −$480.6K | −52.4%5.22K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −19.0K | $83.43 | −$1.59M | −32.9%38.8K after | 2 lots |
| Mar 8, 2023 (view filing) | Mar 6-7 | 2 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −97.0K | $87.67 | −$8.50M | −70.0%41.5K after | 5 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −165 | $84.58 | −$14.0K | −0.6%26.8K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Meyer Colin JohnChief Innovation Officer | SSaleClass A common stock | −621 | $84.57 | −$52.5K | −0.7%84.6K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −622 | $84.70 | −$52.7K | −0.7%88.3K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Wortley Michael DChief Legal Officer | SSaleClass A common stock | −414 | $84.46 | −$35.0K | −0.9%48.1K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −3.96K | $83.46 | −$330.6K | −9.0%40.1K after | |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Meyer Colin JohnChief Innovation Officer | SSaleClass A common stock | −93.9K | $86.72 | −$8.15M | −52.4%85.2K after | 6 lots |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Wortley Michael DChief Legal Officer | SSaleClass A common stock | −2.17K | $87.57 | −$189.9K | −4.3%48.5K after | |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Soni Manmeet SinghCOO, CFO and President | SSaleClass A common stock | −3.59K | $87.97 | −$315.5K | −3.9%88.9K after | |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −1.82K | $88.08 | −$160.2K | −4.1%42.8K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −27.8K | $85.13 | −$2.37M | −38.7%44.1K after | 4 lots |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −820 | $87.47 | −$71.7K | −3.0%26.9K after | |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Bir Dawn CarterChief Commercial Officer | SSaleClass A common stock | −2.17K | $88.25 | −$191.1K | −4.3%48.5K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Huff James WarrenChief Executive Officer | SSaleClass A common stock | −75.0K | $85.46 | −$6.41M | −67.5%36.2K after | 11 lots |
| Jan 4, 2022 (view filing) | Dec 31, 2021 | 4 days | Soni Manmeet SinghCOO and CFO | PPurchaseClass A common stock | +16.0K | $26.22 | +$419.5K | +533.3%19.0K after |